Journal of Thyroid Disorders & Therapy
Open Access

Department of Surgery, Yamashita Thyroid Hospital, 1-8 Shimogofukumachi, Hakata-ku, Fukuoka City, Japan

Biography

Dr. Shinya Satoh is a distinguished surgeon specializing in endocrine surgery at Yamashita Thyroid Hospital in Fukuoka City, Japan. His expertise encompasses the diagnosis and surgical management of thyroid and parathyroid disorders, with a particular focus on fine-needle aspiration (FNA) cytology and minimally invasive surgical techniques. In 2017, Dr. Satoh co-authored the article "Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital," published in the Journal of Pathology and Translational Medicine. This work examines the Japanese approach to FNA cytology for thyroid nodules, highlighting the stratification of follicular neoplasm into subgroups to reduce unnecessary diagnostic thyroidectomies. The study underscores the importance of ultrasound-guided FNA and the measurement of thyroglobulin or calcitonin in FNA needle washings as adjuncts for diagnosing possible cervical lymph node metastasis. In 2013, Dr. Satoh contributed to a case report titled "Thoracoscopic Removal of an Ectopic Parathyroid Adenoma in the Aortopulmonary Window," published in the Journal of the Japanese Surgical Association. This report details a minimally invasive surgical approach for removing an ectopic parathyroid adenoma located in the mediastinum, demonstrating the efficacy of video-assisted thoracoscopic surgery (VATS) in such complex cases. Dr. Satoh's commitment to advancing endocrine surgery is further evidenced by his involvement in research addressing diagnostic challenges in thyroid pathology. He co-authored a study on the "Prevalence and Diagnostic Challenges of Thyroid Lymphoma: A Multi-Institutional Study in Non-Western Countries," published in the Endocrine Journal in 2020. This research provides valuable insights into the occurrence and diagnostic complexities of thyroid lymphoma, emphasizing the need for accurate diagnostic modalities in diverse populations.

Publications

• Research Article   
  Changes in Thyroid Stimulating Antibody Levels in Graves' Disease Patients: Methods to Prevent its Increase after Radioactive Iodine Therapy
  Author(s): Seigo Tachibana*, Tomohiro Ohsako, Yusuke Mori, Hisakazu Shindo, Shinya Satoh, Hiroshi Takahashi and Hiroyuki Yamashita
  
  Background: Although it is well-known that thyroid stimulating antibody levels usually increase after radioactive iodine therapy, we observed various changes in thyroid stimulating antibody levels. Methods: We divided 47 patients who underwent radioactive iodine therapy into two groups based on thyroid stimulating antibody levels three months post-therapy, as follows: the D(3M) group with increasing levels and the I(3M) group with decreasing levels of the antibody. We compared the clinical characteristics of the two groups. In addition, the 47 patients were again divided into the following two groups, and their clinical characteristics were compared: the D(6M) and I(6M) groups, which consisted of patients with decreasing and increasing thyroid stimulating antibody levels, respectively, three to six months after radioactive io.. View More»
  DOI: 10.35248/2167-7948.20.9.241

  Abstract HTML PDF

Other relevant publications from this author

• Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital

  Thoracoscopic Removal of an Ectopic Parathyroid Adenoma in the Aortopulmonary Window

  Prevalence and diagnostic challenges of thyroid lymphoma: a multi-institutional study in non-Western countries